It was found that JMJD3 binding in the SLE group was greatly lower than that in the control group (Figure 2(a)), and there was no obvious difference in the quantities of EZH2 (Figure 2(b)) and UTX (Figure 2(c)) between the two groups. The gene discussed is EZH2; the disease is systemic lupus erythematosus.